United States · FDA National Drug Code directory
Hydrocortisone sodium succinate
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 69097-004_44159bea-88a1-49ac-a51e-1c27dc89d9ff
- Product NDC
- 69097-004
- Form
- INJECTION
- Composition / generic term
- Hydrocortisone sodium succinate
- Labeler
- Cipla USA Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20240925
- Source listing expiry
- 20261231
Source-listed ingredients
- HYDROCORTISONE SODIUM SUCCINATE — 100 mg/2mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL in 1 CARTON (69097-004-67) / 2 mL in 1 VIAL · 69097-004-67
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →